WYNN
37
4
AEP
66
2
PVH
52
2
SYF
64
4
PFE
32
2
STI
45
10
UA
33
7
DE
50
2
GOOGL
50
2
STT
42
2
MCK
52
6
ZION
52
6
FRT
63
10
XRAY
44
3
NEE
54
2
PPG
64
4
PSX
34
2
OMC
62
14
PBI
60
14
CTSH
61
4
WYNN
37
4
AEP
66
2
PVH
52
2
SYF
64
4
PFE
32
2
STI
45
10
UA
33
7
DE
50
2
GOOGL
50
2
STT
42
2
MCK
52
6
ZION
52
6
FRT
63
10
XRAY
44
3
NEE
54
2
PPG
64
4
PSX
34
2
OMC
62
14
PBI
60
14
CTSH
61
4
Financhill
Back

Catalyst Pharmaceuticals Vs. Entrada Therapeutics Industry Stock Comparison

Buy
53

CPRX
Catalyst Pharmaceuticals

Last Price:
20.22
Seasonality Move:
-9.33%
Buy
60

TRDA
Entrada Therapeutics

Last Price:
15.00
Seasonality Move:
13.84%
Buy
53
Catalyst Pharmaceuticals (CPRX) is a Buy

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $20.22. The Score for CPRX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • CPRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Entrada Therapeutics (TRDA) is a Buy

Is Entrada Therapeutics a Buy, Sell or Hold?

  • The current Entrada Therapeutics [TRDA] share price is $15.00. The Score for TRDA is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • TRDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $20.22
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight selling pressure.

TRDA Stock Price Chart

What is Entrada Therapeutics's stock price today?

  • The Entrada Therapeutics share price today is $15.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRDA is experiencing selling pressure, which indicates risk of future bearish movement.

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.41 Buy
Relative Strength Index (14 RSI): 60.16 Buy
Chaikin Money Flow: -187954 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.41 - 20.45) Buy
Bollinger Bands (100): (15.08 - 18.84) Buy

TRDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.29 Sell
Relative Strength Index (14 RSI): 43.63 Sell
Chaikin Money Flow: -59857 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.87 - 16.81) Sell
Bollinger Bands (100): (13.96 - 16.62) Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.79 Buy
20-day SMA: 20.09 Buy
50-day SMA: 18.31 Buy
200-day SMA: 16.03 Buy
8-day EMA: 19.91 Buy
20-day EMA: 19.68 Buy
50-day EMA: 18.62 Buy
200-day EMA: 16.38 Buy

TRDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15 Sell
20-day SMA: 15.99 Sell
50-day SMA: 16.01 Sell
200-day SMA: 14.65 Buy
8-day EMA: 15.17 Sell
20-day EMA: 15.58 Sell
50-day EMA: 15.66 Sell
200-day EMA: 15.01 Sell

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.10 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.

Entrada Therapeutics Earnings Growth & TRDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.35 per share, an increase this year of $0.68 per share, and a decrease next year of $3.79 per share.

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Entrada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):